Future of RNAi-based therapies for human papillomavirus-associated cervical cancer

By Chen Jiezhong   Irving Aaron   McMillan Nigel   Gu Wenyi  

Future Virology, Vol. 2, Iss. 6, 2007-11 ,pp. : 587-595

Future Medicine

Access to resources Recommend Favorite

The Problem of False-Positive Human Papillomavirus DNA Tests in Cervical Screening

By  

Current Pharmaceutical Design, Vol. 19, Iss. 8, 2013-03 ,pp. : 1439-1449

Bentham Science Publishers

Access to resources Recommend Favorite

Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2775-2781

Blackwell Publishing

Access to resources Recommend Favorite

Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma

By Zhang Manchao   Kumar Bhavna   Piao Longzhu   Xie Xiujie   Schmitt Alessandra   Arradaza Nicole   Cippola Michael   Old Matthew   Agrawal Amit   Ozer Enver   Schuller David E.   Teknos Theodoros N.   Pan Quintin  

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 992-1001

Blackwell Publishing

Access to resources Recommend Favorite

The mechanisms behind human papillomavirus-associated cancer: the role of PDZ recognition in malignant progression

By Nagasaka Kazunori   Nakagawa Shunsuke   Yano Tetsu   Taketani Yuji   Banks Lawrence  

Future Virology, Vol. 6, Iss. 6, 2011-06 ,pp. : 675-677

Future Medicine

Access to resources Recommend Favorite